Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific 64Cu-DOTA conjugation

Protein Engineering, Design and Selection

Volumn 27, Issue 10, 2014, Pages 317-324

  Tavaré, Richard ^a   Wu, Wei H ^a   Zettlitz, Kirstin A ^a   Salazar, Felix B ^a   McCabe, Katelyn E ^a   Marks, James D ^b   Wu, Anna M ^a   Neri, Dario ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c NONE

Author keywords

ALCAM; Cu 64; DOTA; ImmunoPET; Site specific conjugation

Indexed keywords

BIOMOLECULES; CELL ADHESION; DIAGNOSIS; ELECTROPHORESIS; MASS SPECTROMETRY; MOLECULES; ORGANIC POLYMERS; SIZE EXCLUSION CHROMATOGRAPHY; TUMORS;

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULES; ALCAM; CELL ADHESION MOLECULES; DETECTION AND DIAGNOSIS; DOTA; IMMUNOPET; PANCREATIC ADENOCARCINOMA; SITE-SPECIFIC;

DISEASES;

1 4 7 10 TETRAAZACYCLODODECANE 1 4 7 10 TETRAACETIC ACID CU 64; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; COPPER; SINGLE HETEROCYCLIC RINGS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; CANCER DIAGNOSIS; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATIC CLEARANCE; HUMAN; HUMAN CELL; IMMUNO POSITRON EMISSION TOMOGRAPHY; KIDNEY TUBULE ABSORPTION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN PURIFICATION; RAT; RENAL CLEARANCE; SITE DIRECTED MUTAGENESIS; SIZE EXCLUSION CHROMATOGRAPHY; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; COLORECTAL TUMOR; DIAGNOSTIC USE; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR IMAGING; PROCEDURES; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COPPER; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RATS; TISSUE DISTRIBUTION;

EID: 84930796171     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzu030     Document Type: Conference Paper

References (50)

1. Abidi, S.M., Saifullah, M.K., Zafiropulos, M.D., Kaput, C, Bowen, M.A., Cotton, C. and Singer, N.G. (2006) J. Clin. Immunol, 26, 12-21.
2. Anderson, C.J. and Ferdani, R. (2009) Cancer Biother. Radiopharm., 24, 379-393.
3. Arano, Y. (1998) Q. J. Nucl. Med., 42, 262-270.
4. Barat, B., Sirk, S.J., McCabe, K.E., et al. (2009) Bioconjug. Chem., 20, 1474-1481.
5. Bowen, M.A., Patel, D.D., Li, X., et al. (1995) J. Exp. Med., 181, 2213-2220.
6. Camarero, J.A. (2008) Biopolymers, 90, 450-458.
7. Chen, R., Yi, E.C., Donohoe, S., et al. (2005) Gastroenterology, 129, 1187-1197.
8. Chitteti, B.R., Kobayashi, M., Cheng, Y., et al. (2014) Blood [Epub ahead of print].
9. Galfre, G. and Milstein, C. (1981) Methods Enzymol., 73, 3-46.
10. Hofstrom, C., Altai, M., Honarvar, H., Strand, J., Malmberg, J., Hosseinimehr, S.J., Orlova, A., Graslund, T. and Tolmachev, V. (2013) J. Med. Chem., 56, 4966-4974.
11. Junutula, J.R., Raab, H., Clark, S., et al. (2008) Nat. Biotechnol., 26, 925-932.
12. Kelly, M.P., Lee, F.T., Tahtis, K., Power, B.E., Smyth, F.E., Brechbiel, M.W., Hudson, P.J. and Scott, A.M. (2008) Cancer Biother. Radiopharm., 23, 411-423.
13. King, J.A., Ofori-Acquah, S.F., Stevens, T., Al-Mehdi, A.B., Fodstad, O. and Jiang, W.G. (2004) Breast Cancer Res., 6, R478-R487.
14. Knowles, S.M. and Wu, A.M. (2012) J Clin Oncol, 30, 3884-3892.
15. Kortt, A.A., Lah, M., Oddie, G.W., et al. (1997) Protein Eng., 10, 423-433.
16. Kristiansen, G., Pilarsky, C., Wissmann, C., et al. (2005) J. Pathol., 205, 359-376.
17. Le Gall, F., Kipriyanov, S.M., Moldenhauer, G. and Little, M. (1999) FEBS Lett., 453, 164-168.
18. Li, L., Olafsen, T., Anderson, A.L., Wu, A., Raubitschek, A.A. and Shively, J.E. (2002) Bioconjug. Chem., 13, 985-995.
19. Liu, B., Conrad, F., Cooperberg, M.R., Kirpotin, D.B. and Marks, J.D. (2004) Cancer Res., 64, 704-710.
20. Liu, B., Conrad, F., Roth, A., Drummond, D.C., Simko, J.P. and Marks, J.D. (2007) J. Mol. Med. (Berl), 85, 1113-1123.
21. Liu, C.C. and Schultz, P.G. (2010) Annu. Rev. Biochem., 79, 413-444.
22. Loening, A.M. and Gambhir, S.S. (2003) Mol. Imaging, 2, 131-137.
23. McCabe, K.E., Liu, B., Marks, J.D., Tomlinson, J.S., Wu, H. and Wu, A.M. (2012) Mol. Imaging Biol., 14, 336-347.
24. Mezzanzanica, D., Fabbi, M., Bagnoli, M., et al. (2008) Clin. Cancer Res., 14, 1726-1733.
25. Ofori-Acquah, S.F. and King, J.A. (2008) Transl. Res., 151, 122-128.
26. Olafsen, T., Cheung, C.W., Yazaki, P.J., et al. (2004) Protein Eng. Des. Sel., 17, 21-27.
27. Olafsen, T., Gu, Z., Sherman, M.A., et al. (2007) J. Immunother., 30, 396-405.
28. Olafsen, T., Sirk, S.J., Betting, D.J., Kenanova, V.E., Bauer, K.B., Ladno, W., Raubitschek, A.A., Timmerman, J.M. and Wu, A.M. (2010) Protein Eng. Des. Sel., 23, 243-249.
29. Patel, D.D., Wee, S.F., Whichard, L.P., Bowen, M.A., Pesando, J.M., Aruffo, A. and Haynes, B.F. (1995) J. Exp. Med., 181, 1563-1568.
30. Schliemann, C., Roesli, C., Kamada, H., Borgia, B., Fugmann, T., Klapper, W. and Neri, D. (2010) Blood, 115, 736-744.
31. Schneider, D.W., Heitner, T., Alicke, B., et al. (2009) J. Nucl. Med., 50, 435-443.
32. Sirk, S.J., Olafsen, T., Barat, B., Bauer, K.B. and Wu, A.M. (2008) Bioconjug. Chem., 19, 2527-2534.
33. Sletten, E.M. and Bertozzi, C.R. (2009) Angew. Chem. Int. Ed. Engl., 48, 6974-6998.
34. Smith, J.R., Chipps, T.J., Ilias, H., Pan, Y. and Appukuttan, B. (2012) Exp. Eye Res., 104, 89-93.
35. Strand, J., Honarvar, H., Perols, A., Orlova, A., Selvaraju, R.K., Karlstrom, A.E. and Tolmachev, V. (2013) PloS ONE, 8, e70028.
36. Strassberger, V., Gutbrodt, K.L., Krall, N., Roesli, C., Takizawa, H., Manz, M.G., Fugmann, T. and Neri, D. (2014) J. Proteomic., 99, 138-151.
37. Swart, G.W., Lunter, P.C., Kilsdonk, J.W. and Kempen, L.C. (2005) Cancer Metastasis Rev., 24, 223-236.
38. Tait, J.F., Smith, C., Levashova, Z., Patel, B., Blankenberg, F.G. and Vanderheyden, J.L. (2006) J. Nucl. Med., 47, 1546-1553.
39. Tavaré, R., Torres Martin De Rosales, R., Blower, P.J. and Mullen, G.E. (2009) Bioconjug. Chem., 20, 2071-2081.
40. Tolmachev, V. and Orlova, A. (2010) Curr. Med. Chem., 17, 2636-2655.
41. van Kempen, L.C., van den Oord, J.J., van Muijen, G.N., Weidle, U.H., Bloemers, H.P. and Swart, G.W. (2000) Am. J. Pathol., 156, 769-774.
42. Vegt, E., de Jong, M., Wetzels, J.F.M., Masereeuw, R., Melis, M., Oyen, W.J.G., Gotthardt, M. and Boerman, O.C. (2010) J. Nucl. Med., 51, 1049-1058.
43. Weichert, W., Knosel, T., Bellach, J., Dietel, M. and Kristiansen, G. (2004) J. Clin. Pathol., 57, 1160-1164.
44. Whitlow, M., Filpula, D., Rollence, M.L., Feng, S.L. and Wood, J.F. (1994) Protein Eng., 7, 1017-1026.
45. Wiiger, M.T., Gehrken, H.B., Fodstad, O., Maelandsmo, G.M. and Andersson, Y. (2010) Cancer Immunol. Immunother., 59, 1665-1674.
46. Wu, A.M. (2009) J. Nucl. Med., 50, 2-5.
47. Wu, A.M. (2014) Methods, 65, 139-147.
48. Wu, A.M. and Senter, P.D. (2005) Nat. Biotechnol., 23, 1137-1146.
49. Wu, A.M., Williams, L.E., Zieran, L., et al. (1999) Tumor Target, 4, 47-58.
50. Yazaki, P.J., Wu, A.M., Tsai, S.W., Williams, L.E., Ikle, D.N., Wong, J.Y.C., Shively, J.E. and Raubitschek, A.A. (2001) Bioconjug. Chem., 12, 220-228.